Form 4: Alto Neuroscience CFO Nicholas Smith Reports Acquisition of Stock Options and Restricted Stock Units
SEC Form 4 Filing
Nicholas Conrad Smith, CFO of Alto Neuroscience, reports the acquisition of stock options and restricted stock units (RSUs) in a recent SEC filing.
Summary
- On March 1, 2024, Nicholas Conrad Smith, the Chief Financial Officer of Alto Neuroscience, Inc. (ANRO), reported transactions involving the company's securities.
- Smith acquired 19,153 shares of common stock through a restricted stock unit (RSU) award.
- These RSUs will vest in two equal installments on September 1, 2025, and March 1, 2026, contingent upon continuous service.
- Each RSU represents the right to receive one share of common stock.
- Smith also acquired an option to purchase 90,000 shares of common stock at an exercise price of $14.88.
- 25% of the shares underlying the option will vest on March 1, 2025, with the remaining shares vesting monthly thereafter, also contingent upon continuous service.
- Following these transactions, Smith directly owns 20,716 shares of common stock and holds options for 90,000 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock and option grants to a key executive. It doesn't inherently indicate positive or negative performance, but rather reflects standard compensation practices.
Positives
- The acquisition of stock options and RSUs by the CFO aligns his interests with those of the shareholders, incentivizing him to work towards the company's success.
- The vesting schedules for both the RSUs and stock options encourage long-term commitment from the CFO.
Future Outlook
The document does not contain specific forward-looking statements about the company's future performance, but the vesting schedules of the RSUs and stock options suggest an expectation of continued service and contribution from the CFO.
Industry Context
This filing is a routine disclosure related to executive compensation and is common for publicly traded companies. It provides transparency into the equity-based compensation structure for key executives.
Stakeholder Impact
- The granting of stock options and RSUs can positively impact shareholders by aligning management's interests with the company's long-term success.
- Employees may view the equity-based compensation as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of earliest transaction: Acquisition of RSUs and stock options. |
| 03/01/2025 | 25% of the shares underlying the option shall vest. |
| 09/01/2025 | First vesting date for half of the RSU award. |
| 03/01/2026 | Second vesting date for the remaining half of the RSU award. |
| 02/28/2034 | Expiration date of the employee stock option. |
| 03/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.